Developmental toxicity assessment of the new fluoroquinolone antibacterial DW‐116 in rabbits
Authors:
- 24 January 2005
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 25 (1) , 52-59
Abstract
DW‐116 is a newly developed fluoroquinolone antibacterial with a broad spectrum against both Gram‐positive and Gram‐negative bacteria. We have reported recently that DW‐116 is embryotoxic and teratogenic in rats. The present study was conducted to investigate the teratogenicity of DW‐116, together with maternal toxicity and developmental toxicity using New Zealand White rabbits. The test chemical was administered by gavage to pregnant rabbits from gestational day (GD) 6 through to GD 18 at dose levels of 0, 5, 19.5 and 76.1 mg kg−1 day−1. All does were subjected to caesarean section on day 28 of gestation and their foetuses were examined for external, visceral and skeletal abnormalities. In the 76.1 mg kg−1 group, a minimal maternal toxicity, as evidenced by decreased body weight gain during treatment period, was observed in pregnant rabbits. Significant embryo‐foetal toxicity, including increased number of foetal deaths and delayed foetal ossification, was seen. However, no treatment‐related morphological changes were detected in foetal external, visceral and skeletal examinations. There were no adverse effects on either pregnant dams or embryo‐foetal development at 19.5 and 5 mg kg−1. It was concluded that administration of DW‐116 during the major organogenetic period in rabbits produced decreased maternal body weight gain, increased number of foetal deaths and foetal developmental delay but no evidence of teratogenicity. The no‐observed‐adverse‐effect levels (NOAELs) of DW‐116 are considered to be 19.5 mg kg−1 day−1 for does and embryo‐foetuses, respectively. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Developmental toxicity of flupyrazofos, a new organophosphorus insecticide, in ratsFood and Chemical Toxicology, 2002
- Correlation between maternal toxicity and embryo/fetal effectsReproductive Toxicology, 1999
- In-vitro and in-vivo activities of DW-116, a new fluoroquinoloneJournal of Antimicrobial Chemotherapy, 1997
- Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo resultsJournal of Antimicrobial Chemotherapy, 1994
- Usefulness of a Simplified Artificial Insemination Technique in the Rabbit for Teratology StudiesExperimental Animals, 1993
- Fluoroquinolone Antimicrobial AgentsNew England Journal of Medicine, 1991
- An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessmentsToxicology, 1989
- Maternal toxicity: A possible etiological factor in embryo‐fetal deaths and fetal malformations of rodent‐rabbit speciesTeratology, 1985
- The effect of acute maternal toxicity on fetal development in the mouseTeratogenesis, Carcinogenesis, and Mutagenesis, 1985
- A Note on the Staining of the Skeleton of Cleared Specimens with Alizarin Red SStain Technology, 1926